1. Comparison of the pharmacokinetics, safety, and immunogenicity of MSB11022, a biosimilar of adalimumab, with Humira® in healthy subjects. (28th July 2016) Authors: Hyland, Elizabeth; Mant, Tim; Vlachos, Pantelis; Attkins, Neil; Ullmann, Martin; Roy, Sanjeev; Wagner, Volker Journal: British journal of clinical pharmacology Issue: Volume 82:Number 4(2016:Oct.) Page Start: 983 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Is there a role of synovial biopsy in drug development?. Issue 1 (December 2016) Authors: Filkova, Maria; Cope, Andrew; Mant, Tim; Galloway, James Journal: BMC musculoskeletal disorders Issue: Volume 17:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Pharmacokinetic equivalence, comparable safety, and immunogenicity of an adalimumab biosimilar product (M923) to Humira in healthy subjects. Issue 1 (8th January 2018) Authors: Hillson, Jan; Mant, Tim; Rosano, Molly; Huntenburg, Carolyn; Alai‐Safar, Mehrshid; Darne, Siddhesh; Palmer, Donna; Pavlova, Borislava G.; Doralt, Jennifer; Reeve, Russell; Goel, Niti; Weilert, Doris; Rhyne, Paul W.; Chance, Kamali; Caminis, John; Roach, James; Ganguly, Tanmoy Journal: Pharmacology research & perspectives Issue: Volume 6:Issue 1(2018) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Pharmacokinetics of fostamatinib, a spleen tyrosine kinase (SYK) inhibitor, in healthy human subjects following single and multiple oral dosing in three phase I studies. (20th June 2013) Authors: Baluom, Muhammad; Grossbard, Elliott B.; Mant, Tim; Lau, David T. W. Journal: British journal of clinical pharmacology Issue: Volume 76:Number 1(2013:Jul.) Page Start: 78 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PRT062607 Achieves Complete Inhibition of the Spleen Tyrosine Kinase at Tolerated Exposures Following Oral Dosing in Healthy Volunteers. (17th August 2016) Authors: Coffey, Greg; Rani, Aradhana; Betz, Andreas; Pak, Yvonne; Haberstock‐Debic, Helena; Pandey, Anjali; Hollenbach, Stanley; Gretler, Daniel D.; Mant, Tim; Jurcevic, Stipo; Sinha, Uma Journal: Journal of clinical pharmacology Issue: Volume 57:Number 2(2017) Page Start: 194 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Safety, tolerability, pharmacokinetics, and efficacy of AMG 403, a human anti-nerve growth factor monoclonal antibody, in two phase I studies with healthy volunteers and knee osteoarthritis subjects. Issue 1 (December 2015) Authors: Gow, Jason; Tsuji, Wayne; Williams, Gary; Mytych, Daniel; Sciberras, David; Searle, Shawn; Mant, Tim; Gibbs, John Journal: Arthritis research & therapy Issue: Volume 17:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Targeting of antithrombin in hemophilia A or B with investigational siRNA therapeutic fitusiran—Results of the phase 1 inhibitor cohort. (18th May 2021) Authors: Pasi, K. John; Lissitchkov, Toshko; Mamonov, Vasily; Mant, Tim; Timofeeva, Margarita; Bagot, Catherine; Chowdary, Pratima; Georgiev, Pencho; Gercheva‐Kyuchukova, Liana; Madigan, Kate; Van Nguyen, Huy; Yu, Qifeng; Mei, Baisong; Benson, Craig C.; Ragni, Margaret V. Journal: Journal of thrombosis and haemostasis Issue: Volume 19:Number 6(2021) Page Start: 1436 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗